Brief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Yesterday 16:42
BRIEF-Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate June 16 (Reuters) - Lee's Pharmaceutical Holdings Ltd 0950.HK:
ANNOUNCES SHARE REPURCHASE PROGRAM UNDER REPURCHASE MANDATE
TO REPURCHASE UP TO HK$50 MILLION IN SHARES FROM 16 JUNE 2026 TO NEXT AGM
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA